BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Inven2 - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Inven2
X-ORIGINAL-URL:https://www.inven2.com/?lang=en
X-WR-CALDESC:Events for Inven2
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Oslo
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20201019T100000
DTEND;TZID=Europe/Oslo:20201019T120000
DTSTAMP:20260417T072724
CREATED:20201013T084931Z
LAST-MODIFIED:20201014T082620Z
UID:7279-1603101600-1603108800@www.inven2.com
SUMMARY:Norwegian Health Investor Network
DESCRIPTION:Valuation Through A Health Lense & What Professional Investors Look For When Investing\nJoin us for an overview of health-focused company valuation methods by a valuation expert\, followed by a walk-through of the decision making process used by seasoned investors when they invested early (and subsequently followed-on) in one of Norway’s most successful biotech companies\, Vaccibody. \n– Vaccibody just secured the largest Biotech deal Norway has ever seen. \nModerator: Jeremy McCrohan\, Norwegian Health Investor Network (Head of Investor Relations\, Norway Health Tech)
URL:https://www.inven2.com/events/norwegian-health-investor-network/?lang=en
CATEGORIES:Innovation
ATTACH;FMTTYPE=image/png:https://www.inven2.com/wp-content/uploads/2020/10/Norwegian-Helth-Investor-Network2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20200903T090000
DTEND;TZID=Europe/Oslo:20200903T153000
DTSTAMP:20260417T072724
CREATED:20200818T112122Z
LAST-MODIFIED:20200824T134205Z
UID:6616-1599123600-1599147000@www.inven2.com
SUMMARY:Webinar: Course in clinical funded studies
DESCRIPTION:The course is practically oriented and is primarily aimed at testers\, study nurses\, project coordinators and others who work with clinical studies on behalf of the industry\, primarily drug studies. \nWe go through the entire process\, from requesting participation to closing and archiving\, what obligations and benefits study participation entails for the hospital and what expectations the industry has. It is an advantage to have completed GCP courses\, as the course presupposes a certain knowledge of regulations and concepts.
URL:https://www.inven2.com/events/course-in-clinical-funded-studies/?lang=en
LOCATION:Forskningsparken\, Gaustadalleen 21\, Oslo\, 0346\, Norge
CATEGORIES:Clinical trials
ATTACH;FMTTYPE=image/jpeg:https://www.inven2.com/wp-content/uploads/2020/08/shutterstock_787865590_web2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20200827T083000
DTEND;TZID=Europe/Oslo:20200827T100000
DTSTAMP:20260417T072724
CREATED:20200818T111554Z
LAST-MODIFIED:20200818T130606Z
UID:6615-1598517000-1598522400@www.inven2.com
SUMMARY:Webinar: Internationalization of clinical trials in Norway?
DESCRIPTION:Can the Norwegian ambition around clinical studies be exported? Why is it important? Sign up and see the complete invitation and program here:  \nhttps://www.novartis.no/internasjonalisering-av-kliniske-studier-i-norge \nor follow the streaming live by signing up for the Facebook event. \nA collaboration meeting between GSK\, Inven2 and Novartis
URL:https://www.inven2.com/events/webinar-internasjonalization-of-clinical-studies-in-norway/?lang=en
CATEGORIES:Clinical trials
ATTACH;FMTTYPE=image/jpeg:https://www.inven2.com/wp-content/uploads/2020/08/MEMO-Kliniske-studier_møte-27-aug-2020-FB_LinkedIn-event-banner.jpg
END:VEVENT
END:VCALENDAR